PD32-05 PHASE I CLINICAL STUDY ON THE COMBINATION THERAPY OF CHP-NY-ESO-1 CANCER VACCINE AND MIS416 FOR THE TREATMENT OF PATIENTS WITH NY-ESO-1 EXPRESSING REFRACTORY UROTHELIAL CANCER OR CASTRATION-RESISTANT PROSTATE CANCER
Takeshi Sasaki
◽
Mikiya Ishihara
◽
Hideki Kanda
◽
Yasuhide Hori
◽
Norihito Soga
◽
...
2015 ◽
Vol 64
(4)
◽
pp. 493-505
◽
Masanori Noguchi
◽
Gaku Arai
◽
Kazumasa Matsumoto
◽
Seiji Naito
◽
Fukuko Moriya
◽
...
2010 ◽
Vol 183
(6)
◽
pp. 2219-2226
◽
William D. Figg
◽
Sukyung Woo
◽
Wenhui Zhu
◽
Xiaohong Chen
◽
A. Seun Ajiboye
◽
...
Masanori Noguchi
◽
Shigetaka Suekane
◽
Fukuko Moriya
◽
Tetsuro Sasada
◽
Akira Yamada
◽
...
Christopher J. Sweeney
◽
Katherine Zukotynski
◽
Xiaodong Wang
◽
Andrew Wick
◽
Amanda Fredericks
◽
...
2015 ◽
Vol 13
(2)
◽
pp. 113-123
◽
Kevin D. Courtney
◽
Judith B. Manola
◽
Aymen A. Elfiky
◽
Robert Ross
◽
William K. Oh
◽
...
2016 ◽
Vol 21
(5)
◽
pp. 535
◽
Neeraj Agarwal
◽
Jean‐Pascal Machiels
◽
Cristina Suárez
◽
Nancy Lewis
◽
Michaela Higgins
◽
...
2018 ◽
Vol 24
(21)
◽
pp. 5225-5232
◽
Shilpa Gupta
◽
Luke T. Nordquist
◽
Mark T. Fleming
◽
William R. Berry
◽
Jingsong Zhang
◽
...
2018 ◽
Vol 13
(8)
◽
pp. e0202709
Michael T. Schweizer
◽
Kathleen Haugk
◽
Jožefa S. McKiernan
◽
Roman Gulati
◽
Heather H. Cheng
◽
...
Hiroshi Nakayama
◽
Yoshitaka Sekine
◽
Daisuke Oka
◽
Yoshiyuki Miyazawa
◽
Seiji Arai
◽
...
Close
Export Citation Format
Close
Share Document
Close